Who Paid My Doc
Systemic Sclerosis (ILD) pivotal study
Research payments
$24,832
Through program year 2024, $24,832 in research payments was reported against Systemic Sclerosis (ILD) pivotal study, across 107 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH & Co.KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $18,638 | 1 |
| 2019 | Research | $6,194 | 106 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Maureen Mayes Houston, TX Named on 5 payments
- Aryeh Fischer Denver, CO Named on 4 payments
- Lawrence Ho Seattle, WA Named on 4 payments
- Laura Hummers Baltimore, MD Named on 3 payments
- Mary Scholand Salt Lake City, UT Named on 3 payments
- Ankoor Shah Durham, NC Named on 3 payments
- Anthony Gerbino Seattle, WA Named on 3 payments
- Srihari Veeraraghavan Atlanta, GA Named on 3 payments
- Lisa Lancaster Nashville, TN Named on 3 payments
- Danielle Antin-Ozerkis New Haven, CT Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.